• 1
    Pileri, S. A., D. D. Weisenburger, I. Sng, E. S. Jaffe, E. Ralfkiaer, S. Nakamura, 2009. Peripheral T-cell lymphoma, not otherwise specified. Pp. 306309 in S. H. Swerdlow, E. Campo, N. L. Haris, E. S. Jaffe, S. A. Pileri, H. Stein, et al., eds. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. 4th ed. IARC Press, Lyon, France.
  • 2
    Weisenburger, D. D., K. J. Savage, N. L. Haris, R. D. Gascoyne, E. S. Jaffe, K. A. MacLennan, et al. 2011. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117:34023408.
  • 3
    International T-cell Lymphoma Project. 2008. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol. 26:41244130.
  • 4
    Shimoyama, M. 1991. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br. J. Haematol. 79:428437.
  • 5
    Suzumiya, J., K. Ohshima, K. Tamura, K. Karube, N. Uike, K. Tobinai, et al. 2009. The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project. Ann. Oncol. 20:715721.
  • 6
    Umino, A., M. Nakagawa, A. Utsunomiya, K. Tsukasaki, N. Taira, N. Katayama, et al. 2011. Clonal evolution of adult T-cell leukemia/lymphoma takes place in the lymph nodes. Blood 117:54735478.
  • 7
    Nakagawa, M., A. Nakagawa-Oshiro, S. Karnan, H. Tagawa, A. Utsunomiya, S. Nakamura, et al. 2009. Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia/lymphoma. Clin. Cancer Res. 15:3038.
  • 8
    Karube, K., M. Nakagawa, S. Tsuzuki, I. Takeuchi, K. Honma, Y. Nakashima, et al. 2011. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 118:31953204.
  • 9
    Tsuchiya, T., K. Ohshima, K. Karube, T. Yamaguchi, H. Suefuji, M. Hamasaki, et al. 2004. Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood 103:236241.
  • 10
    Ballester, B., O. Ramuz, C. Gisselbrecht, G. Doucet, L. Loï, B. Loriod, et al. 2006. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 25:15601570.
  • 11
    Piccaluga, P. P., C. Agostinalli, A. Califano, M. Rossi, M. Basso, S. Zupo, et al. 2007. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J. Clin. Invest. 117:823834.
  • 12
    Yamamoto, K., A. Utsunomiya, K. Tobinai, K. Tsukasaki, N. Uike, K. Uozumi, et al. 2010. Phase I Study of KW-0671, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J. Clin. Oncol. 28:15911598.
  • 13
    Ding, L., T. J. Ley, D. E. Larson, C. A. Miller, D. C. Koboldt, J. S. Welch, et al. 2012. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481:506510.